Zadnja posodobitev :
08/05/2024
Antibiotik   Colistin mesilate sodium  
Brizgalka
Aerosol
Stabilnost raztopine Stabilnost mešanice Faktorji, ki vplivajo na stabilnost Kompatibilnost Način aplikacije Viri Pdf
   Kemična formula  

Lastniško ime   Lastniško ime     

Sestava pomožnih snovi je med paralelami lahko različna

Alfacolin Argentina
Alficetin Argentina
Colent Čile
Colimicina Italija, Španija
Colimycin Danska, Norveška, Turčija
Colimycine Francija, Luksemburg, Maroko, Nizozemska, Tunizija
Colismet Peru
Colisti Ject Egipt
Colistimetal sodic Romunija
Colistimetato de sodio Čile, Peru, Španija
Colistimethate Kanada, Velika Britanija, Združene države Amerike
Colistin Avstrija, Grčija, Nova Zelandija, Poljska
Colistina Argentina, Portugalska
Colistineb Belgija
Colistyn Argentina
Colixin Portugalska
Colomycin Irska, Kanada, Malezija, Velika Britanija, Združene države Amerike
Coly-Mycin Avstralija, Združene države Amerike
Cotrelan Argentina
Dicupal Čile
Elistin Peru
Kolisod Turčija
Nolisin Argentina
Promixin Irska, Norveška, Velika Britanija
Toliscrin Argentina
Viri   Brizgalka   Viri : Colistin mesilate sodium  
Tip Objava
1201 časopis Yuhas EM, Lofton FT, Rosenberg HA, Mayron D, Baldinus JG.
Cimetidine hydrochloride compatibility III: Room temperature stability in drug admixtures.
Am J Hosp Pharm 1981 ; 38: 1919-1922.
2285 časopis Wallace SJ, Li J, Rayner CR, Coulthard K, Nation RL.
Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients.
Antimicrob Agents Chemother 2008 ; 52, 9: 3047-3051.
2550 časopis Roberts GW, Rossi S.O.P.
Compatibility of nebulizer solutions
Aust J Hosp Pharm 1993 ; 23: 35-37.
2783 časopis Abdulla A,.van Leeuwen R.W.F, de Vries Schultink A.H.M,.Koch B.C.P.
Stability of colistimethate sodium in a disposable elastomeric infusion device.
Int J Pharm 2015 ; 486; 1-2: 367-369.
3254 časopis Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L.
Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration
Am J Health-Syst Pharm 2011 ; 68: 2265-2270.
3360 časopis Healan A. M, Gray W, Fuchs E.J, Griffiss J.M, Salata R.A, Blumer J.
Stability of Colistimethate Sodium in Aqueous Solution.
Antimicrob Agents Chemother 2012 ; 56:6432-6433.
3674 Traduction Laboratorij Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
3827 Poster Ghazi I.M, Hamada Y, Nicolau D.P.
Compatibility of tedizolid phosphate with selected intravenous drugs via simulated Y-site conditions.
ASHP Midyear 2015
3828 Poster Thabit A.K, Hamada Y, Nicolau D.P.
Ceftozolane/tazobactam physical compatibility during simulated Y-site administration.
ASHP Midyear 2015
3829 Poster So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L.
Compatibility of isavunazonium sulfate during simulated Y-site administration.
ASHP Midyear 2015
3997 časopis Katip W.
Visual compatibility of colistin injection with other antibiotics during simulated Y-site administration.
Am J Health-Syst Pharm 2017 ; 74:14 : 1099-1102
4055 časopis Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D.
Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 , 75, 1:36-44
4145 časopis Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P.
Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 ;75,14:1048-1056
4178 časopis Post T.E, Kamerling I, van Rossen R, Burggraaf J, Stevens J, Dijkmans A, Heijerman H, Touw D, van Velzen A, Wilms E.
Colistin methanesulfonate infusion solutions are stable over time and suitable for home administration.
EJHP 2017 ; 25, e2
4319 časopis Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G.
Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs.
Hosp Pharm 2020 ; 55, 5: 332-337.
4434 časopis Avery L.M, Chen, I.H, Reyes, S, Nicolau, D.P, Kuti J.L.
Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration.
Clin Ther 2019 ; 41, 10: 2162-2170.
4438 časopis Stawny M, Gostyńska A, Nadolna M, Jelińska A.
Safe Practice of Y-Site Drug Administration: The Case of Colistin and Parenteral Nutrition
Pharmaceutics 2020 ; 12: 292
4528 časopis Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N.
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration.
Int J Pharm Compound 2021 ;25,1:52-61
4801 časopis Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J.
Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2024 ;51,1:

  Mentions Légales